Pharmacokinetic and Pharmacodynamic Interaction Between DWP16001, an SGLT2 Inhibitor, and Metformin in Healthy Subjects.
Byungwook KimKi Young HuhJun Gi HwangJae Jin NahWan HuhJae Min ChoIn-Jin JangKyung-Sang YuYun KimSeung Hwan LeePublished in: British journal of clinical pharmacology (2022)
The results suggest that DWP16001 and metformin could be coadministered without clinically relevant PK and PD interactions.
Keyphrases